Pfizer Insider Trades
NYSE: PFEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:02 PM ET · Delayed 15 min
Pre-market: 27.82 -0.04%
Last 12 months
- Purchases
- 3 · $2.96M
- Sales
- 2 · $134.66K
- Shares bought / sold
- 114.86K / 5.28K
- Net activity
- Net buying $2.8 million
Pfizer insider activity
Over the last 12 months, Pfizer insiders reported 5 transactions on SEC Form 4: 3 open-market purchases and 2 sales. Insiders bought $3.0 million and sold $134,661 worth of stock, for net insider buying of $2.8 million. The largest seller was DAMICO JENNIFER B., with $134,661 in reported sales.
The most recent filing shows BOURLA ALBERT (Chairman & CEO) buying 38,000 shares at $26.34 on Aug 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PFE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PFE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 12, 2026 | BOURLA ALBERTChairman & CEO | Buy | 38,000 | $1.00M | Form 4 |
| Aug 5, 2026 | Buckley Mortimer JDirector | Buy | 37,632 | $960.37K | Form 4 |
| Aug 5, 2026 | BLAYLOCK RONALD EDirector | Buy | 39,231 | $998.82K | Form 4 |
| Aug 5, 2026 | DAMICO JENNIFER B.SVP & Controller | Sale | 3,278 | $83.26K | Form 4 |
| Jun 9, 2026 | DAMICO JENNIFER B.SVP & Controller | Sale | 2,000 | $51.40K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4